Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Inhaled Iloprost will be administered to near term infants with Persistent Pulmonary
Hypertension of the Newborn in two different doses in order to test safety and efficacy in
reducing pulmonary artery pressure.